Steroid withdrawal in kidney allograft recipients

被引:3
|
作者
Adesina, Sanni [1 ,2 ]
Alkhudhayri, Abdullah [1 ,2 ,3 ]
Patel, Jyodi Kiran [1 ,2 ]
Naufal, Mary [1 ,2 ]
Geara, Abdallah [4 ]
Azzi, Jamil [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Transplantat Res Ctr, Div Renal, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA
[3] King Faisal Specialist Hosp & Res Ctr, Dept Surg, Riyadh 12713, Saudi Arabia
[4] W Virginia Univ, Sch Med, Dept Med, Div Nephrol, Bridgeport, WV 26330 USA
关键词
acute rejection; allograft; calcineurin; cyclosporine; glomerulonephritis; immunosuppression; interstitial fibrosis and tubular atrophy; mycophenolate mofetil; new onset diabetes after transplantation; surveillance biopsy; RENAL-TRANSPLANT RECIPIENTS; FREE MAINTENANCE IMMUNOSUPPRESSION; EARLY CORTICOSTEROID WITHDRAWAL; TOTAL BODY IRRADIATION; LONG-TERM; PROTOCOL BIOPSIES; RECEIVING SIROLIMUS; THERAPY; CYCLOSPORINE; MULTICENTER;
D O I
10.1586/1744666X.2014.946406
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This review highlights the aggregate of knowledge obtained from the temporal trend of kidney transplant immune suppression. We will discuss the burden of steroid side effects and their impact on quality of life in kidney allograft recipients, which have led to minimizing steroid exposure. Issues arising since the inception of the concept of steroid withdrawal will be discussed, along with how they have continually led to a shift in research focus on this subject matter. The usefulness of surveillance biopsies and how further elucidation of the pathophysiology of interstitial fibrosis and tubular atrophy could contribute to improving long-term allograft outcomes will also be discussed. We will elaborate on the role of calcineurin inhibitor minimization alongside steroid withdrawal in improving long-term graft survival. Future expectations of subsequent studies with a view to improving overall kidney allograft outcomes by eliminating attendant problems associated with steroids will also be covered.
引用
收藏
页码:1229 / 1239
页数:11
相关论文
共 50 条
  • [31] Steroid avoidance or withdrawal for pancreas and pancreas with kidney transplant recipients
    Montero, Nuria
    Webster, Angela C.
    Royuela, Ana
    Zamora, Javier
    Crespo Barrio, Marta
    Pascual, Julio
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (09):
  • [32] Early Steroid Withdrawal in Repeat Kidney Transplantation
    Mujtaba, Muhammad A.
    Taber, Tim E.
    Goggins, William C.
    Yaqub, Muhammad S.
    Mishler, Dennis P.
    Milgrom, Martin L.
    Fridell, Jonathan A.
    Lobashevsky, Andrew
    Powelson, John A.
    Sharfuddin, Asif A.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (02): : 404 - 411
  • [33] Prospective Controlled Protocol for Three Months Steroid Withdrawal with Tacrolimus, Basiliximab, and Mycophenolate Mofetil in Renal Transplant Recipients
    Oh, Chang-Kwon
    Kim, Su Jin
    Kim, Ji Hye
    Lee, Jong Hoon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2012, 27 (04) : 337 - 342
  • [34] Steroid withdrawal after renal transplantation: a retrospective cohort study
    Haller, Maria C.
    Kammer, Michael
    Kainz, Alexander
    Baer, Heather J.
    Heinze, Georg
    Oberbauer, Rainer
    BMC MEDICINE, 2017, 15
  • [35] Comparing early withdrawal or avoidance of steroids with standard steroid therapy in kidney transplant recipients
    Hricik, Donald E.
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2008, 4 (07): : 360 - 361
  • [36] Outcomes of Steroid-Avoidance Protocols in Pediatric Kidney Transplant Recipients
    Nehus, E.
    Goebel, J.
    Abraham, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (12) : 3441 - 3448
  • [37] Outcomes With Conversion From Calcineurin Inhibitors to Sirolimus After Renal Transplantation in the Context of Steroid Withdrawal or Steroid Continuation
    Egbuna, Ogo I.
    Davis, Roger B.
    Chudinski, Robyn
    Pavlakis, Martha
    Rogers, Christin
    Molakatalla, Phani
    Johnson, Scott R.
    Karp, Seth
    Monaco, Anthony P.
    Tang, Hongying
    Hanto, Douglas W.
    Mandelbrot, Didier A.
    TRANSPLANTATION, 2009, 88 (05) : 684 - 692
  • [38] Outcomes of Early Steroid Withdrawal in Recipients of Deceased-Donor Expanded Criteria Kidney Transplants in the Era of Induction Therapy
    Hussain, Sabiha M.
    Marcus, Richard J.
    Ko, Tina Y.
    Nashar, Khaled
    Thai, Ngoc L.
    Sureshkumar, Kalathil K.
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2016, 14 (03) : 287 - 293
  • [39] Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant Recipients
    Hricik, Donald E.
    Formica, Richard N.
    Nickerson, Peter
    Rush, David
    Fairchild, Robert L.
    Poggio, Emilio D.
    Gibson, Ian W.
    Wiebe, Chris
    Tinckam, Kathryn
    Bunnapradist, Suphamai
    Samaniego-Picota, Milagros
    Brennan, Daniel C.
    Schroeppel, Bernd
    Gaber, Osama
    Armstrong, Brian
    Ikle, David
    Diop, Helena
    Bridges, Nancy D.
    Heeger, Peter S.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 26 (12): : 3114 - 3122
  • [40] Steroid withdrawal or avoidance is safe in high-risk kidney transplants: A systematic review and meta-analysis
    Song, Tu-Run
    Jian, Ya-Mei
    Liu, Jin-Peng
    Wang, Zhi-Ling
    Zeng, Jun
    Huang, Zhong-Li
    Fan, Yu
    Wang, Xian-Ding
    Lin, Tao
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2019, 35 (06) : 350 - 357